兰格林
幼年黄色肉芽肿
朗格汉斯细胞组织细胞增多症
组织细胞增多症
免疫分型
病理
组织细胞
埃尔德海姆-切斯特病
罗赛-多夫曼病
川地68
表型
朗格汉斯细胞
医学
生物
疾病
树突状细胞
免疫学
免疫组织化学
免疫系统
抗原
生物化学
基因
作者
Sylvie Fraïtag,Jean‐François Emile
摘要
Cutaneous histiocytoses constitute a heterogeneous group of diseases characterised by the cutaneous accumulation of cells with the cytological and phenotypic features of macrophages or dendritic cells. The clinical spectrum ranges from self-resolving, skin-limited conditions to severe, multiorgan disease with a high morbidity rate. Until recently, cutaneous histiocytoses were classified according to the immunophenotype of the pathological cells, with differentiation between Langerhans cell histiocytosis (LCH) [CD1a+, CD207 (langerin)+] and non-Langerhans cell histiocytosis (CD68+, CD163+, CD1a-, CD207-). Over the last 12 years, a number of new pathophysiological findings (in particular, molecular pathology results) regarding histiocytoses have contributed to a new classification based on molecular alterations, as well as on clinical and imaging characteristics and the phenotype. The most frequent entities in children are juvenile xanthogranuloma and LCH.
科研通智能强力驱动
Strongly Powered by AbleSci AI